Stockreport

Down -30.2% in 4 Weeks, Here's Why MaxCyte (MXCT) Looks Ripe for a Turnaround [Yahoo! Finance]

MaxCyte, Inc.  (MXCT) 
PDF After declining 30.2% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement amo [Read more]